The global Organ‑On‑Chip Market reached USD 78.4 million in 2024 and is forecast to grow to USD 651 million by 2033, expanding at a CAGR of 25.2 %, driven by adoption in pharmaceutical R&D, toxicology studies, and regulatory shifts favoring humane testing. North America leads with over 50% share, while Asia‑Pacific—at ~29% CAGR—and Europe are rapidly scaling up, supported by innovatio... https://www.datamintelligence.com/research-report/organ-on-chip-market